The Utility of Preoperative Tumor Markers in Peritoneal Carcinomatosis from Primary Appendiceal Adenocarcinoma: an Analysis from the US HIPEC Collaborative.
Fackche N, Schmocker RK, Kubi B, Cloyd JM, Ahmed A, Grotz T, Leiting J, Fournier K, Lee AJ, Powers B, Dineen S, Veerapong J, Baumgartner JM, Clarke C, Gamblin TC, Patel SH, Dhar V, Hendrix RJ, Lambert L, Abbott DE, Pokrzywa C, Lafaro K, Lee B, Zaidi MY, Maithel SK, Johnston FM, Greer JB.
Fackche N, et al.
J Gastrointest Surg. 2021 Nov;25(11):2908-2919. doi: 10.1007/s11605-021-04953-y. Epub 2021 Feb 25.
J Gastrointest Surg. 2021.
PMID: 33634422
This study aims to determine the value of preoperative tumor markers as predictors of progression-free survival (PFS) and overall survival (OS) for patients with peritoneal carcinomatosis from a primary mucinous adenocarcinoma of the appendix (M …
This study aims to determine the value of preoperative tumor markers as predictors of progression-free survival (PFS) and overall survival ( …